Empowering your company save money & valuable time by helping you take control of your SaaS stack. And helping you find and save on exciting & relevant software tools to do more, better, quicker, and cheaper.
Trusted by tens of thousands of small and mid-sized companies, startups, service providers, freelancers and agencies worldwide.
Consolidate and control SaaS payments & all other expenses in one account. Use separate virtual credit cards to pay each vendor, with tight limits. Get real-time visibility, control, & security.
Each SaaS product is at least somewhat differentiated. And your company is unique. So let us match you with the product that is right for you. Oh, and let’s make sure you’re not missing out on the latest & greatest products.
With NachoNacho, you can stay confident - (1) You'll never get overcharged (2) Give you peace of mind while signing up, knowing that you'll be able to find/review transactions easily and in one location (3) It's an intuitive platform.
Demand Generation Lead
Got SaaS? You need NachoNacho
NachoNacho is arguably one of the most important tools we use. Keeping our finances in check while not handing out our company or personal cards to 20-30 different SaaS subscriptions has been a game-changer for us as a company.
Perfect tool to keep subscriptions & expenses under control
We've been using NachoNacho for a few years now, and it's an absolutely fantastic platform to create cards for the company and the team and keep all subscriptions and expenses under tight control.
Co-founder at Zeroqode
Convenient, great control/oversight, saves countless hours!
NachoNacho just keeps getting better! It gives each department buying power and control over their subscriptions and one-time expenses. It's effortless to manage cards and issue new ones, saving me a lot of time.
Head of Finance
Simple product that works perfectly
I've been using NachoNacho for a while, and it's been great! It gives me a much better sense of our spending across our various SaaS subscriptions and has saved us $$$ when a supposedly-extended trial wasn't actually extended.